BioSpace News Archive

Applied Genetic Technologies Corporation today announced Sue Washer, President and Chief Executive Officer of AGTC, will present at the 2021 Cell & Gene Meeting on the Mesa being held October 12-14, 2021.

Rakovina Therapeutics Inc. today announced a summary of the Company’s presentation at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics, which was held virtually on October 7-10, 2021.

Cytovia Therapeutics, Inc., a biopharmaceutical company developing allogeneic “off-the-shelf” gene-edited iNK and CAR -iNK cells derived from induced pluripotent stem cells and Flex-NK™ cell engager multifunctional antibodies, announced that Evelyn D’An has been appointed as Chief Financial Officer.

Magnolia Medical Technologies, Inc., inventors of Steripath®, today announced it has been awarded a national GPO and Value-Based contract with Premier Inc.

A quick stick in the arm with an approved COVID-19 vaccine elicits a flurry of activity in the body’s immune system.

AUM Biosciences announced the successful completion of USD $27 million series A funding round.

Sandy J. Falk, MD, has been named Editor-in-Chief of the Merck Manuals, a digital medical reference available for free to all both online at www.MerckManuals.com and as mobile apps with versions for healthcare professionals and consumers.

Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, announced it will report financial results for the third quarter 2021 after market close on Tuesday, November 9, 2021.

Homology Medicines, Inc., a genetic medicines company, announced the pheEDIT Phase 1 clinical trial for HMI-103, a one-time, in vivo product candidate that utilizes a gene editing approach for phenylketonuria, based on the Investigational New Drug Application clearance from the U.S. Food and Drug Administration.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced preliminary financial results for its third quarter ended September 30, 2021.